BRBrian M. Ross

Brian M. Ross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brian M. Ross has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 March 2010
      • Vol. 19  (1) , 15-20

    A preliminary investigation of exhaled breath from patients with celiac disease using selected ion flow tube mass spectrometry.

    by Alexa Hryniuk, Brian M Ross

    Breath diagnostics, the measurement of volatile chemicals in human breath, is currently receiving attention as a technique for the detection of disease which, being non-invasive in nature, is particularly suited to screening for pre-symptomatic disease in healthy populations. A disorder in which more effective screening would be beneficial is celiac disease (CD), an under-diagnosed autoimmune disease of the small intestine characterized by nutritional malabsorption, which presents with diverse, and sometimes serious, symptoms. We aimed to determine whether breath analyses could be used to screen for the presence of CD. Based on our hypotheses that malabsorption of dietary carbohydrates would lead to over production of alcohol fermentation products in the large intestine, we investigated levels of alcohols in the breath of 10 patients with CD compared to that in 10 healthy controls using selected ion flow tube mass spectrometry (SIFT-MS). No differences were found in the breath levels of methanol, propanol, butanol, heptanol or hexanol investigated using chemical ionization of breath air with H3O+ and/or NO+ precursor ions. In one patient, diagnosed within days of our study and not currently in receipt of any therapeutic intervention, a relatively high production of three product ions was detected compared to all other study patients. Our data suggest that breath alcohol levels are unlikely to be of diagnostic use in CD, although further investigation of those recently diagnosed with the disorder may be warranted.


  • The reactions of H 3 O + , NO + and O with several flavourant esters studied using selected ion flow tube mass spectrometry

    by Liana Iachetta, Lada Malek, Brian M. Ross

    The reactions of H 3 O + , NO + , and O with nineteen ester compounds occurring naturally in plants, and having important flavourant properties, were examined using selected ion flow tube mass spectrometry (SIFT‐MS). The H 3 O + reactions primarily generate [R 1 COOR 2 ·H] + , and may also produce [R 2 ] + fragment ions and/or fragmentation within the ester linkage. Collisional association/adduct ions, [R 1 COOR 2 ·NO] + , are the main products formed in the NO + reactions, although the carboxyl fragment ion is also detected frequently. The identification of the parent compound may be made more easily in the H 3 O + and NO + reactions. The inclusion of O reactions in the analysis provides additional information, which may be applied when the identity of a parent compound cannot be determined solely from the H 3 O + and NO + analysis. Consideration of the product ions generated with the three precursors suggests that SIFT‐MS can differentiate between many of the esters investigated, including isomers, although the product ions generated in the reactions with some esters are too similar to allow independent quantification. Our data therefore suggest that SIFT‐MS may be a useful tool to rapidly analyse and quantify flavourant esters in complex gas mixtures. Copyright © 2010 John Wiley & Sons, Ltd.


  • The use of selected ion flow tube mass spectrometry to detect and quantify polyamines in headspace gas and oral air

    by Brian M. Ross, Slim Babay, Chelsea Ladouceur

    Polyamines are a class of aliphatic compounds which include putrescine, cadaverine, spermine and spermidine. They are involved in a variety of cellular processes and have been implicated in a number of different pathophysiological mechanisms. Polyamines are volatile compounds having a distinctive odour normally perceived as being unpleasant. The measurement of their abundance has, however, been restricted to compounds present in the aqueous phase. Using selected ion flow tube mass spectrometry (SIFT‐MS) we have shown that the polyamines react with the ions H 3 O + , NO + and O to form distinctive product ions allowing their levels to be quantified in the vapour phase. The low volatility of spermine did not allow extensive analysis of this compound by SIFT‐MS while the adherent properties of cadaverine and putrescine required the use of PTFE transfer lines and couplers. Our data suggested the presence of cadaverine and putrescine in both oral air and the headspace of putrefying bovine muscle, while product ions corresponding to putrescine and spermidine were found in the headspace of human semen. SIFT‐MS therefore appears to be a practical means of measuring vapour‐phase polyamine levels, having applications in biology, medicine and dentistry, and food science. Copyright © 2009 John Wiley & Sons, Ltd.


  • Open Access

    A comparison of oxidative stress in smokers and non-smokers: an in vivo human quantitative study of n-3 lipid peroxidation

    by Basant K Puri, Ian H Treasaden, Massimo Cocchi, Sofia Tsaluchidu, Lucio Tonello, Brian M Ross

    Background: Cigarette smoking is believed to cause oxidative stress by several mechanisms, including direct damage by radical species and the inflammatory response induced by smoking, and would therefore be expected to cause increased lipid peroxidation. The aim was to carry out the first study of the relationship of smoking in humans to the level of n-3 lipid peroxidation indexed by the level of ethane in exhaled breath. Methods: Samples of alveolar air were obtained from 11 smokers and 18 non-smokers. The air samples were analyzed for ethane using mass spectrometry. Results: The two groups of subjects were matched with respect to age and gender. The mean cumulative smoking status of the smokers was 11.8 (standard error 2.5) pack-years. The mean level of ethane in the alveolar breath of the group of smokers (2.53 (0.55) ppb) was not significantly different from that of the group of non-smokers (2.59 (0.29) ppb; p = 0.92). With all 29 subjects included, the Spearman rank correlation coefficient between ethane levels and cumulative smoking status was -0.11 (p = 0.58), while an analysis including only the smokers yielded a corresponding correlation coefficient of 0.11 (p = 0.75). Conclusion: Our results show no evidence that cigarette smoking is related to increased n-3 lipid peroxidation as measured by expired ethane.


  • Open Access

    Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans

    by Basant K Puri, Serena J Counsell, Brian M Ross, Gavin Hamilton, Marcelo G Bustos, Ian H Treasaden

    This study tested the hypothesis that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans. Ethane is released specifically following peroxidation of n-3 polyunsaturated fatty acids. We reasoned that the cerebral source of ethane would be the docosahexaenoic acid component of membrane phospholipids. Breakdown of the latter also releases phosphorylated polar head groups, giving rise to glycerophosphorylcholine and glycerophosphorylethanolamine, which can be measured from the 31-phosphorus neurospectroscopy phosphodiester peak. Schizophrenia patients were chosen because of evidence of increased free radical-mediated damage and cerebral lipid peroxidation in this disorder.


  • Open Access

    Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'

    by Brian M Ross, Martin Katzman

    The topical application of methylnicotinate results in a localized vasodilatatory response which has been found to differ from that observed to occur in healthy controls in a variety of medical conditions. The stability of the drug in aqueous solution is unclear while difficulties can be encountered when preparing methylnicotinate solutions for this purpose. To aid in the determination of how long solutions of the drug should be stored before discarding we have used a collection of aged batches of methylnicotinate to determine the stability of the drug in aqueous solution.


  • Open Access

    Sub-parts per billion detection of trace volatile chemicals in human breath using Selected Ion Flow Tube Mass Spectrometry

    by Brian M Ross

    Selected ion flow tube mass spectrometry (SIFT-MS) allows the real time quantification of trace gases in air. Due to its tolerance of high humidity levels the technique is particularly suited to the chemical analysis of breath. The detection limit of SIFT-MS has previously reported to be approximately 5 – 10 PPBV which is insufficient for the measurement of some low abundance constituents of breath. Recent developments in the design of SIFT-MS instruments have increased the ion precursor count rates. It is, however, unclear as to how these advances will affect instrument sensitivity for breath analysis.


  • The combined use of thermal desorption and selected ion flow tube mass spectrometry for the quantification of xylene and toluene in air

    by Brian M. Ross, Natasha Vermeulen

    Thermal desorption (TD) is commonly employed for volatile chemical analysis, it being the method of choice for occupational health and safety monitoring. TD allows for offline capture of volatiles onto a solid sorbent followed by desorption and analysis at a later time. Although TD is routinely used in conjunction with gas chromatography (TD‐GC), the assay throughput is low and requires the use of gas standards for quantification. Another technique increasingly employed for volatile chemical analysis, selected ion flow tube mass spectrometry (SIFT‐MS), is capable of real‐time absolute (i.e. without calibration standards) quantification of volatile chemicals present at single digit parts per billion or higher concentrations. SIFT‐MS is, however, normally used for online direct analysis of gas samples rather than offline collection and analysis. The goal of this study was to determine whether a combination of TD and SIFT‐MS could be used to quantify volatile compounds, specifically xylene and toluene, more rapidly than TD‐GC and without the need for calibration standards. SIFT‐MS was able to quantify xylene and toluene levels within 45 s of desorption. Due to the robustness of the SIFT‐MS analysis in the presence of water vapour and other major components of air, the purging of tubes usually required to remove these constituents during the TD cycle was not required, therefore reducing the TD cycle time. Comparing the quantity of xylene and toluene applied to the TD tube with the absolute levels quantified by SIFT‐MS subsequent to desorption suggested a recovery of over 95% of the applied compound. We conclude that the combination of TD and SIFT‐MS allows more rapid and accurate quantification of xylene and toluene (compared with TD‐GC) to be achieved without the need for calibration standards, features which may be advantageous in applications requiring rapid analysis and high throughput. Copyright © 2007 John Wiley & Sons, Ltd.


  • Open Access

    Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?

    by Brian M. Ross, Jennifer Seguin, Lee E Sieswerda

    A growing number of observational and epidemiological studies have suggested that mental illness, in particular mood disorders, is associated with reduced dietary intake and/or cellular abundance of omega-3 polyunsaturated fatty acids (PUFA). This has prompted researchers to test the efficacy of omega-3 PUFA in a range of different psychiatric disorders. We have critically reviewed the double blind placebo controlled clinical trials published prior to April 2007 to determine whether omega-3 PUFA are likely to be efficacious in these disorders. Most trials involved a small number of participants but were largely well designed. Omega-3 PUFA were well tolerated by both children and adults with mild gastrointestinal effects being the only consistently reported adverse event. For schizophrenia and borderline personality disorder we found little evidence of a robust clinically relevant effect. In the case of attention deficit hyperactivity disorder and related disorders, most trials showed at most small benefits over placebo. A limited meta-analysis of these trials suggested that benefits of omega-3 PUFA supplementation may be greater in a classroom setting than at home. Some evidence indicates that omega-3 PUFA may reduce symptoms of anxiety although the data is preliminary and inconclusive. The most convincing evidence for beneficial effects of omega-3 PUFA is to be found in mood disorders. A meta-analysis of trials involving patients with major depressive disorder and bipolar disorder provided evidence that omega-3 PUFA supplementation reduces symptoms of depression. Furthermore, meta-regression analysis suggests that supplementation with eicosapentaenoic acid may be more beneficial in mood disorders than with docosahexaenoic acid, although several confounding factors prevented a definitive conclusion being made regarding which species of omega-3 PUFA is most beneficial. The mechanisms underlying the apparent efficacy of omega-3 PUFA in mood disorders compared to schizophrenia are discussed as is a rational for the possibly greater efficacy of EPA compared to DHA. While it is not currently possible to recommend omega-3 PUFA as either a mono- or adjunctive-therapy in any mental illness, the available evidence is strong enough to justify continued study, especially with regard to attentional, anxiety and mood disorders.